Axogen, Inc.
Develops surgical solutions, including nerve allografts, for peripheral nerve repair and regeneration.
AXGN | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 13631 PROGRESS BLVD., 32615 ALACHUA
- Website:
- https://www.axogeninc.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Axogen, Inc. is a company focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides a portfolio of surgical solutions to restore nerve function and improve the quality of life for patients with nerve injuries. Its primary products include the Avance® Nerve Graft, a processed human nerve allograft for bridging nerve discontinuities, alongside other technologies for nerve protection and connection. Axogen's mission is to make the restoration of peripheral nerve function an expected standard of care, serving surgeons and healthcare professionals who treat patients with complex nerve damage.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-31 21:09 |
Director's Dealing
FORM 4
|
English | 8.7 KB | ||
| 2025-10-29 21:07 |
Quarterly Report
FORM 10-Q
|
English | 1.3 MB | ||
| 2025-10-29 12:03 |
Earnings Release
FORM 8-K
|
English | 2.4 MB | ||
| 2025-10-24 22:09 |
Director's Dealing
FORM 4
|
English | 7.5 KB | ||
| 2025-10-07 23:18 |
Director's Dealing
FORM 4
|
English | 7.5 KB | ||
| 2025-10-06 22:54 |
Director's Dealing
FORM 4
|
English | 8.0 KB | ||
| 2025-09-16 23:22 |
Director's Dealing
FORM 4
|
English | 7.4 KB | ||
| 2025-08-25 12:41 |
Regulatory News Service
FORM 8-K - FDA BLA UPDATE
|
English | 133.4 KB | ||
| 2025-08-05 23:13 |
Registration Form
FORM S-8
|
English | 76.6 KB | ||
| 2025-08-05 22:52 |
Quarterly Report
FORM 10-Q
|
English | 1.2 MB | ||
| 2025-08-05 13:02 |
Earnings Release
FORM 8-K
|
English | 2.4 MB | ||
| 2025-06-20 22:11 |
Director's Dealing
FORM 4
|
English | 7.5 KB | ||
| 2025-06-20 22:10 |
Director's Dealing
FORM 4
|
English | 7.3 KB | ||
| 2025-06-20 22:09 |
Director's Dealing
FORM 4
|
English | 7.5 KB | ||
| 2025-06-20 22:09 |
Director's Dealing
FORM 4
|
English | 7.5 KB |
Automate Your Workflow. Get a real-time feed of all Axogen, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Axogen, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Axogen, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
